Funding for this research was provided by:
National Institutes of Health (CA195564)
National Natural Science Foundation of China (81801781)
Received: 5 July 2019
Accepted: 11 September 2019
First Online: 18 September 2019
Ethics approval and consent to participate
: Our study initially involved 4704 patients who presented initially clinically for breast DCE-MRI examinations as recorded in the Department of Breast Imaging of the Tianjin Medical University Cancer Institute and Hospital. As this study involved a retrospective collection of images and data and an anonymized machine learning study, informed consent was waived and the study was deemed exempt by the IRB at the University of Chicago.
: We consent for publication.
: MLG is a stockholder in R2 Technology/Hologic and a cofounder, equity holder, and scientific advisor in Quantitative Insights. MLG receives royalties from Hologic, GE Medical Systems, MEDIAN Technologies, Riverain Medical, Mitsubishi, and Toshiba. It is the University of Chicago Conflict of Interest Policy that investigators disclose publicly actual or potential significant financial interest that would reasonably appear to be directly and significantly affected by the research activities.